Top ten global pharmaceutical group reduces seven year RISE TCO by thirty eight percent.

The opening position.

The pharmaceutical group operated on a complex SAP estate spanning corporate finance, manufacturing execution, clinical supply, and research informatics. Four SAP instances ran in production. Two of those instances were validated under twenty one CFR Part eleven and supported GxP processes for manufacturing batch release and clinical supply tracking. The SAP account team proposed a single RISE with SAP Cloud Private Edition contract covering all four instances, with a unified Digital Access entitlement, bundled BTP credits, and a single hyperscaler provider across all workloads.

Three issues surfaced in the opening review. The Digital Access entitlement was sized against an unverified document volume estimate that ran ahead of historical actuals. The hyperscaler choice was being made without separating validated regions from non validated regions, which had downstream implications for qualification and audit. The RISE standard contract carried audit assistance clauses that required the regulated business to depend on SAP cooperation timelines that did not match its FDA inspection commitments.

The engagement was scoped at eighteen weeks. Six weeks for discovery and workload classification. Six weeks for parallel TCO modelling across three deployment options. Six weeks for counter proposal, negotiation, and signature.

Four phase negotiation sequence.

What the model showed.

The Digital Access entitlement inside the original proposal was sized against twenty two million documents per year across the four instances. Historical document counts from three years of order entry, batch release, and clinical supply transactions came in at thirteen point four million, with growth at three percent rather than the eight percent assumed in the proposal. The proposal entitlement was running at sixty four percent above the volume the group could reasonably commit to.

The four instance bundle inside the proposal was modelled as a single tenant, single region deployment. A workload by workload analysis showed that the two non validated instances were strong candidates for RISE Cloud Private Edition, while the two validated instances carried qualification and audit obligations that made a separate brownfield deployment on dedicated infrastructure the lower risk option across seven years. Pulling the validated workloads out of RISE reduced the bundled commitment by forty one percent and removed nine separate audit clauses from the negotiation surface.

The bundled BTP credits were priced against a roadmap including six integration projects. Three of those projects had funded business cases. Three did not. The BTP credit allocation was rebuilt to match only the funded roadmap, with a usage based mechanism for the remainder. The hyperscaler choice was decoupled from the RISE bundle, which gave the group the ability to select different providers for the validated and non validated workloads based on regional qualification status.

Pulling the two validated instances out of the RISE bundle reduced the commitment by forty one percent and removed nine audit clauses that did not match the group's FDA inspection commitments.

What changed at signature.

The final RISE contract closed at $36M seven year TCO across the two non validated instances. The two validated instances remained on a separate brownfield deployment with dedicated infrastructure, which the group preferred for audit and qualification reasons. Total seven year TCO across all four instances landed at thirty eight percent below the original consolidated proposal, with measurably lower audit risk and clearer separation of duties between the RISE and non RISE estates.

Eleven GxP audit clauses were rewritten across the final RISE contract. SAP committed to a forty eight hour audit notification window, dedicated audit support resources during FDA inspection windows, and a documented chain of custody for any RISE managed environment changes that touched qualified configuration items. The Digital Access entitlement was rebased to fourteen million documents per year across the two RISE instances, with a true up mechanism rather than a flat commitment.

The five year price lock at signature carried no annual uplift through years one to five. Years six and seven carried a documented uplift schedule capped at four percent annually. Exit credits were added against early termination scenarios, with transition assistance committed for fifteen months post termination and data extraction in an open format inside a ninety day extraction window.